RapidShock analysis added to Zoll AEDs
ZOLL Medical Corporation has announced that the company’s ZOLL AED 3 and the ZOLL AED BLS automated external defibrillators now feature RapidShock Analysis technology.
ZOLL Medical Corporation, an Asahi Kasei Group Company that manufactures medical devices and related software solutions, has announced that the company’s ZOLL AED 3 and the ZOLL AED BLS automated external defibrillators now feature RapidShock Analysis technology, which decreases heart analysis time and pauses in chest compressions. RapidShock Analysis can analyse a heart rhythm in three seconds - existing devices can take up to 12 seconds. Minimising CPR pause time for more continuous lifesaving CPR care can improve patient outcomes from sudden cardiac arrest. RapidShock Analysis is a free upgrade to existing ZOLL AED 3 owners in countries where it has regulatory approval.
“We’re pleased to be able to add this breakthrough technology to the ZOLL AED 3. It is critical to deliver consistent, high-quality chest compressions, and this technology dramatically reduces pauses, allowing for high-quality CPR,” said A. Ernest Whiton, president of ZOLL Resuscitation.